[Treatment of osteoporosis with antiresorptive drugs]

Ugeskr Laeger. 2005 Feb 21;167(8):883-7.
[Article in Danish]
No abstract available

Publication types

  • Review

MeSH terms

  • Bone Density / drug effects
  • Bone Resorption / drug therapy*
  • Calcitonin / administration & dosage
  • Calcium / administration & dosage
  • Cholecalciferol / administration & dosage
  • Diphosphonates / administration & dosage
  • Estradiol / administration & dosage
  • Estrogens, Conjugated (USP) / administration & dosage
  • Female
  • Humans
  • Male
  • Osteoporosis / drug therapy*
  • Osteoporosis / prevention & control
  • Osteoporosis, Postmenopausal / drug therapy*
  • Osteoporosis, Postmenopausal / prevention & control
  • Progesterone / administration & dosage
  • Raloxifene Hydrochloride / administration & dosage
  • Selective Estrogen Receptor Modulators / administration & dosage
  • Vitamin D / administration & dosage

Substances

  • Diphosphonates
  • Estrogens, Conjugated (USP)
  • Selective Estrogen Receptor Modulators
  • Vitamin D
  • Cholecalciferol
  • Raloxifene Hydrochloride
  • Progesterone
  • Estradiol
  • Calcitonin
  • Calcium